Kusajili – Clinical trials directory

Result of your search per sponsor: Protherics Development Medicines Ltd

Woman and Man Max 99 years
Protherics Development Medicines Ltd Update Il y a 4 ans

A PHASE 2 STUDY OF THE ANTI-TUMOUR ACTIVITY AND SAFETY OF PROLARIX™ IN HEPATOCELLULAR CARCINOMA (HCC) To evaluate the overall response rate [ie, proportion of subjects with complete response (CR) and partial response (PR)] to treatment with Prolarix at the MTD determined in a previous Phase 1 study (2...

Country None
organs None
Specialty None

Closed trial

More information